178 related articles for article (PubMed ID: 23595183)
61. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
[TBL] [Abstract][Full Text] [Related]
62. Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.
Petri M
Curr Rheumatol Rep; 2011 Feb; 13(1):77-80. PubMed ID: 20978875
[TBL] [Abstract][Full Text] [Related]
63. Bilateral osteonecrosis of the talus and "standing obsession" in a patient with anorexia nervosa.
Milos G; Willi J; Häuselmann H
Int J Eat Disord; 2001 Apr; 29(3):363-9. PubMed ID: 11262519
[TBL] [Abstract][Full Text] [Related]
64. Thrombotic microangiopathy involving the gallbladder as an unusual manifestation of systemic lupus erythematosus and antiphospholipid syndrome: Case report and review of the literature.
De-Leon-Bojorge B; Zaltzman-Girsevich S; Ortega-Salgado A; Prieto-Patron A; Córdoba-Córdoba R; Yamazaki-Nakashimada M
World J Gastroenterol; 2006 Nov; 12(44):7206-9. PubMed ID: 17131489
[TBL] [Abstract][Full Text] [Related]
65. [Multiple osseous avascular necrosis in a patient with systemic lupus erythematosus with antiphospholipid antibody positivity].
Biasi D; Caramaschi P; Pacor ML; Carletto A; Melchiori S; Manzo T; Bambara LM
Recenti Prog Med; 1995 Nov; 86(11):449-50. PubMed ID: 8539478
[No Abstract] [Full Text] [Related]
66. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
67. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus.
Derksen RH; Gmelig-Meijling FH; de Groot PG
Lupus; 1996 Feb; 5(1):77-80. PubMed ID: 8646232
[TBL] [Abstract][Full Text] [Related]
68. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?
Mok MY; Farewell VT; Isenberg DA
Ann Rheum Dis; 2000 Jun; 59(6):462-7. PubMed ID: 10834864
[TBL] [Abstract][Full Text] [Related]
69. [Primary antiphospholipid syndrome].
Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
[TBL] [Abstract][Full Text] [Related]
70. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
Wahl DG; Bounameaux H; de Moerloose P; Sarasin FP
Arch Intern Med; 2000 Jul; 160(13):2042-8. PubMed ID: 10888978
[TBL] [Abstract][Full Text] [Related]
71. Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant.
Nagasawa K; Tada Y; Koarada S; Tsukamoto H; Horiuchi T; Yoshizawa S; Murai K; Ueda A; Haruta Y; Ohta A
Lupus; 2006; 15(6):354-7. PubMed ID: 16830881
[TBL] [Abstract][Full Text] [Related]
72. Renal infarction in a severely hypertensive patient with lupus erythematosus and antiphospholipid antibodies.
Hernández D; Dominguez ML; Diaz F; Fernandez ML; Lorenzo V; Rodriguez A; Torres A
Nephron; 1996; 72(2):298-301. PubMed ID: 8684543
[TBL] [Abstract][Full Text] [Related]
73. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus, secondary antiphospholipid syndrome and IgM monoclonal paraproteinaemia.
Nagy L; Hannema A; Swaak A
Clin Rheumatol; 1999; 18(1):56-8. PubMed ID: 10088953
[TBL] [Abstract][Full Text] [Related]
74. Clinical characteristics of multifocal osteonecrosis in Korean patients with rheumatic disease.
Jeong HJ; Kim D; Cho SK; Kim Y; Bae SC; Sung YK
Int J Rheum Dis; 2018 Jun; 21(6):1301-1308. PubMed ID: 28328178
[TBL] [Abstract][Full Text] [Related]
75. Widespread cutaneous necrosis associated with antiphospholipid syndrome.
Jou IM; Liu MF; Chao SC
Clin Rheumatol; 1996 Jul; 15(4):394-8. PubMed ID: 8853176
[TBL] [Abstract][Full Text] [Related]
76. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
77. Ictus and antiphospholipid syndrome: how much is enough?
Rodríguez-Castellano E; Ríos-Blanco JJ; Robles-Marhuenda A; Gil-Aguado A; Soto-Abánades C; Pérez-Valero I; Royo-Orejas A; Vázquez-Rodríguez JJ
Autoimmunity; 2008 Mar; 41(2):140-2. PubMed ID: 18324483
[TBL] [Abstract][Full Text] [Related]
78. Avascular necrosis of a single vertebral body, an atypical site of disease in a secondary APLS.
Mok MY; Isenberg DA
Ann Rheum Dis; 2000 Jun; 59(6):494-5. PubMed ID: 10885980
[No Abstract] [Full Text] [Related]
79. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Przepiera-Będzak H; Brzosko M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
[TBL] [Abstract][Full Text] [Related]
80. Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature.
El-Gendy H; El-Gohary RM; Mahfouz S; Ahmed HMA; El Demerdash DM; Ragab G
Platelets; 2019; 30(5):664-671. PubMed ID: 30373491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
